Reduced levels of BMP7 in primary breast and lung cancer tissues are significantly associated with the formation of clinically overt bone metastases for breast cancer patients and lymph node metastasis for lung cancer patients [43, 44]. Here, BMP7 is linked to lung carcinoma.